Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03605095Completed
Trial of nitroglycerin (2 arms), sponsored by Semmelweis University. Primary endpoint: Blood flow change after application of NO agonist. Started Jul 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03605095.